The market for pressure monitoring devices in Peru is experiencing significant growth, primarily driven by the rising prevalence of noncommunicable diseases (NCDs), an aging population, and a robust commitment from the government towards enhancing digital health and healthcare infrastructure. NCDs, particularly hypertension, pose a serious health challenge in Peru. In 2019, the country reported 19,059 deaths attributed to hypertension, which translates to a relatively low mortality rate of 56.1 per 100,000 individuals when compared to other nations. However, data spanning from 2014 to 2022 reveals a troubling trend: approximately 20% of the Peruvian population suffers from hypertension, yet less than half are aware of their condition, and only 5% manage to keep their blood pressure under control. Additionally, there has been a notable increase in metabolic risk factors such as obesity and elevated fasting blood glucose levels across the Americas from 2000 to 2021, further complicating the public health landscape.
The demographic changes in Peru are also contributing to the demand for pressure monitoring devices. The total population is expected to reach around 34.58 million by 2025, with a median age of 30.2 years. Notably, the segment of the population aged 65 and older is projected to grow to 9% by 2025, up from 8.99% in 2023. This demographic shift is likely to result in a higher prevalence of age-related health issues, necessitating ongoing monitoring and management of chronic conditions.
Technological advancements and the push for digital health are significantly influencing the pressure monitoring device market. There is a concerted effort to enhance the governance of healthcare quality and to create an interoperable health information system, which are crucial for developing a more cohesive healthcare framework. The integration of artificial intelligence (AI) into the healthcare sector in Peru is gaining recognition for its potential to improve diagnostic accuracy and treatment efficiency. However, challenges remain, particularly in rural areas where access to technology is limited and digital infrastructure is lacking.
The Peruvian government is actively supporting the modernization of the healthcare system. Over the years, the country has made substantial strides in improving healthcare delivery, which has led to better health outcomes and increased health insurance coverage. The Integral Health Insurance (SIS) has been instrumental in providing access to healthcare for impoverished and underserved rural populations. Despite these advancements, the healthcare system in Peru still faces significant challenges, including fragmentation and underfunding. In 2022, only 6.2% of the country's GDP was allocated to health, which is considerably lower than both regional and international benchmarks.
The General Directorate of Medicines, Supplies, and Drugs (DIGEMID) serves as the regulatory authority for medical devices in Peru, playing a crucial role in ensuring that health products are safe and of high quality. All medical devices must be registered with DIGEMID before they can be marketed, and they are classified according to risk levels (Classes I, II, III, and IV) in accordance with international standards such as the European Directive 93/42/EEC. This regulatory framework is essential for addressing the health needs of the population, responding to demographic changes, and facilitating a proactive approach to the digital transformation of healthcare in Peru.
In summary, the pressure monitoring devices market in Peru is poised for growth due to the increasing burden of NCDs, particularly hypertension, and the aging population. The government's commitment to digital health transformation and infrastructure development is also a significant driver. While there are challenges related to awareness and management of hypertension among the population, as well as issues of healthcare funding and access, the ongoing efforts to modernize the healthcare system and integrate technology hold promise for improving health outcomes in the country. As Peru continues to navigate these challenges, the role of regulatory bodies like DIGEMID will be vital in ensuring that the healthcare system can meet the evolving needs of its population.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook